title: Treatment of anaemia in CAPD patients with recombinant human erythropoietin.
abstract: EPO is an effective therapy of anaemia in CAPD patients. Monitoring serum iron level during EPO therapy is essential. Hypertension is frequently seen in patients with EPO therapy.
authors.affiliation: Nephrology Unit of E. Angelli, Pinerolo, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Ramello
authors.forename: U
authors.initials: U
authors.lastname: Malcangi
authors.forename: M
authors.initials: M
authors.lastname: Bruno
authors.forename: P
authors.initials: P
authors.lastname: Perosa
authors.forename: E
authors.initials: E
authors.lastname: Reina
authors.forename: A
authors.initials: A
authors.lastname: Rizzuto
authors.forename: M G
authors.initials: MG
authors.lastname: Nasini
authors.forename: S
authors.initials: S
authors.lastname: Carozzi
mesh_terms: D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D001794:Blood Pressure / Q000187:drug effects; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007501:Iron / Q000097:blood; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin; D007501:Iron